What the headlines get wrong about dermal filler
28 May 2026
By Dr Sophie Shotter
Over the last couple of years, dermal filler has been treated like the villain of aesthetic medicine. You’ll have seen the same storyline repeated in slightly different outfits: filler is “over”, patients want “natural only”, and clinics are “moving away from it and reaching for ‘regenerative’ options instead”. It makes for great clicks because as a society we’re fascinated by aesthetic treatments and people are always looking for ways for vilify them.
But it’s not a particularly accurate description of what’s happening in good practice. Dermal filler hasn’t vanished. What has changed is our collective understanding of how faces age, what filler can realistically do, and how often it should be used. The media has turned that evolution into a morality tale. In clinic, it’s something far more practical: better planning, better patient education, and better outcomes.
The media doesn’t report aesthetics, it reports aesthetics culture
Most coverage of filler isn’t really about medicine. It’s about aesthetics as a cultural battleground. Articles aren’t written to help a reader understand product rheology, facial anatomy, or risk management. They’re written to provoke a reaction.
That warps perception. The public ends up believing filler is either a magic wand or a reckless gamble, depending on which headline they read that day. In reality, hyaluronic acid filler is a medical device with a clear set of strengths, a clear set of limitations, and a risk profile that depends heavily on clinician skill, patient selection, and treatment planning.
The problem is that nuance doesn’t travel well online. A careful conversation about structural support and proportion will never outperform a dramatic “filler gone wrong” clip in terms of engagement.
Why we only notice bad filler
There’s a cognitive bias at play that the media amplifies: we notice what’s obvious. Subtle, well-integrated filler doesn’t register as “filler” because it doesn’t change identity – it simply restores support. So it doesn’t become an example, a screenshot, or a cautionary tale.
Overdone filler does the opposite. It alters proportions and movement in ways the brain finds unfamiliar. It’s instantly recognisable, which is exactly why it ends up used as evidence that “filler always looks like that”. That’s how perception becomes skewed: the cases that are easiest to spot are assumed to be the norm.
In practice, the best filler work often disappears into the person’s face. We don’t notice it – we simply look at that person and think they look really well.
The biggest misunderstanding: Filler isn’t a line eraser
A lot of the filler backlash comes from a period when filler was treated as a quick fix for any visible ageing. A line appeared, so it was filled. A fold deepened, so more was added. In some patients and some areas that approach can soften a problem temporarily, but it often fails because it ignores what’s actually driving the change.
Faces don’t age in neat little creases. Ageing is structural. Bone subtly remodels, fat compartments change, retaining ligaments loosen, and the skin itself changes in thickness and elasticity. The face loses support and proportion before it develops individual lines.
When you understand that, you stop asking filler to do jobs it was never designed for, and that’s where modern outcomes improve dramatically.
What filler does exceptionally well
Hyaluronic acid filler still does some things better than almost anything else we currently have. It restores support where tissue has thinned or shifted. It refines contour and improves proportion. It allows precise, targeted structural support in ways that energy-based devices and skin boosters simply can’t replicate.
That’s why it’s misleading when headlines suggest filler is obsolete. It’s not obsolete, it’s specific.
If a patient has lost midface support, a well-planned structural approach can reduce shadowing, soften the appearance of lower face heaviness, and restore balance in a way that looks natural in motion. If temples have hollowed, restoring that framework can change how the whole upper face reads without making anyone look “done”. If the chin is retruded, small amounts of support can improve facial harmony and lower facial balance.
We’re not following trends, we’re restoring structural support, and that’s the distinction the media rarely makes.
“Pillow face” isn’t inevitable
The heavy, puffy “overfilled” look that people associate with filler usually comes from one thing: using volume to compensate for laxity and skin quality change.
Filler does not tighten loose skin on its own. It does not rebuild collagen in a meaningful long-term way. It does not correct crepey texture or significantly improve skin quality. When filler is used to chase those outcomes, the face can start to look weighty, swollen, or strangely uniform.
The field has improved because we’ve become better at separating problems. If the issue is laxity, a collagen-stimulating or tightening strategy should lead. If the issue is skin quality, then skin boosters, biostimulators, and energy-based treatments make more sense. Filler then becomes what it should always have been: targeted structural support within a broader plan.
Dermal filler is a medical procedure with real risks.
Another media pattern is swinging between extremes: filler is either portrayed as casual beauty maintenance or as inherently dangerous. Neither is responsible.
The most serious complication is vascular occlusion, when filler inadvertently enters a blood vessel and blocks blood flow. In very rare cases this can affect the back of the eye, causing blindeness. That’s rare, but it’s why anatomical knowledge, careful technique, appropriate product choice, and the ability to recognise and manage complications matter. It’s also why a bargain price should never be the deciding factor. You aren’t paying for the syringe. You’re paying for judgement, anatomy, and risk management.
Safety also depends on not treating indiscriminately. Patient selection matters – as does pacing and a clinician’s willingness to say no.
Migration and longevity: What’s true and what’s exaggerated
“Migration” has become another headline-friendly word, often used as if it’s an automatic outcome. Migration can of course happen. It’s more likely with poor technique, overly superficial placement, repeated top-ups without reassessment, and using larger volumes than the tissue can sensibly accommodate.
But not every puffiness is migration. Faces change, weight fluctuates, lymphatic drainage varies, and ageing progresses. What people interpret as “migration” is sometimes simply the wrong treatment being used for the wrong problem, or a plan that wasn’t reviewed properly over time.
This is one of the most important evolutions in modern practice: reassessment. The old habit of topping up on autopilot is being replaced with more thoughtful planning, longer intervals, and a focus on the face as a whole rather than on one feature.
One of the most unhelpful ideas the media has popularised is the notion that patients now want “natural only” and therefore filler is out.
Natural is not a treatment category, it’s an outcome. A natural result is one where the face still looks like the person, the proportions make sense, the features move normally, and the change is believable. That outcome can include filler, anti-wrinkle injections, collagen stimulation, skin boosters, or skincare. What it doesn’t include is over-treatment, rushed planning, or trend-led work.
In other words, filler isn’t the opposite of natural – poor planning is.
What good filler practice actually looks like now
Modern aesthetic planning starts differently. It rarely begins with “what do you want to treat?” It begins with questions about what you’ve noticed, what bothers you, and what still looks like you.
Then we assess structure, skin quality, and movement. We think about how the face is ageing across each layer, not just where a crease has appeared. We also think ahead, because a treatment should not only look good next week, it should still look good in a year.
When that approach guides treatment, filler becomes more strategic, it becomes less frequent, and results become more stable.
The headlines suggest filler is disappearing. The reality is that aesthetic medicine has matured. We’ve become better at matching the tool to the biology, and filler has moved from being the centrepiece to being one component of a wider strategy.
Dermal filler still has a vital role when the issue is structural support or volume loss. What’s changed is the philosophy around it: less chasing lines, more restoring framework, and far more respect for what filler can’t do.
Considering aesthetic treatments and want to understand what’s right for you? Book a consultation in my Harley Street, Marylebone Clinic and we’ll assess your concerns and put a plan together that’s right for you.